p38MAPK family isoform p38α and activating transcription factor 2 are associated with the malignant phenotypes and poor prognosis of patients with ovarian adenocarcinoma

In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer

Ramona Rudalska, Daniel Dauch, Thomas Longerich et al. · Nature Medicine · 2014 · 277 citations · Full text

Medicine, Molecular Biology, Oncology +16

The Activation of c-Jun NH2-terminal Kinase (JNK) by DNA-damaging Agents Serves to Promote Drug Resistance via Activating Transcription Factor 2 (ATF2)-dependent Enhanced DNA Repair

Jun Hayakawa, Chantal Depatie, Masahide Ohmichi et al. · Journal of Biological Chemistry · 2003 · 163 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Optimal first-line treatment in ovarian cancer

F. Raja, Neha Chopra, Jonathan A. Ledermann · Annals of Oncology · 2012 · 154 citations · Full text

Medicine, Gynecology, Oncology +13

Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX

Dimitri Van Simaeys, Dalia López‐Colón, Kwame Sefah et al. · PLoS ONE · 2010 · 108 citations · Full text

Medicine, Molecular Biology, Oncology +17

Suppressor role of activating transcription factor 2 (ATF2) in skin cancer

Anindita Bhoumik, Boris Fichtman, Charles DeRossi et al. · Proceedings of the National Academy of Sciences · 2008 · 92 citations · Full text

Medicine, Dermatology, Oncology +14